Medical and Pharmaceutical GRAIL plunges hard after ‘Galleri’ multi-cancer test fails to meet primary endpoint The slide comes in tandem with financial results that beat expectations Rowan Dunne7 days ago
Medical and Pharmaceutical Researchers replicate natural immune signaling to improve cancer immunotherapy The work came from scientists at the University of Southampton’s Centre for Cancer Immunology Joseph MortonJanuary 13, 2026
Crypto/Blockchain Liminatus Pharma shares spike 26% on Digital Asset focused capital raise plans The engagement builds upon Liminatus’s previously announced review of a blockchain-integrated treasury strategy Joseph MortonJuly 24, 2025
Medical and Pharmaceutical Japanese startup ‘Craif’ raises US$22M to bring urine cancer biopsy to the U.S. Japan's venture capital firm X&KSK led the Series C round Rowan DunneApril 28, 2025
Medical and Pharmaceutical Chinese researchers develop breath analysis tech for lung cancer detection It works by identifying abnormal levels of isoprene -- a volatile organic compound Rowan DunneNovember 6, 2024
Medical and Pharmaceutical bioAffinity Technologies makes phlegm lung cancer test widely available to Veterans The University of California says 15 veterans die from lung cancer around the world every day Rowan DunneOctober 9, 2024
Medical and Pharmaceutical From Kentucky to Nevada: $6.8M grant aims to spread lung cancer screening success Kentucky has more cases of lung cancer than any other state, but it has one of the highest screening rates Rowan DunneSeptember 19, 2024
Medical and Pharmaceutical UK hospital starts using advanced robotic tool for early-stage lung cancer detection This "Ion Endoluminal System" enables doctors to access hard-to-reach areas of the lungs Rowan DunneSeptember 18, 2024
AI and Autonomy AI capable of identifying lung cancer years before symptoms manifest Qure.ai just showcased the capabilities of its AI-powered chest X-ray at the World Conference on Lung Cancer Rowan DunneSeptember 11, 2024
Medical and Pharmaceutical Summit Therapeutics up 55% as lung cancer drug outperforms Merck’s Analysts have now given the company a much higher share target price too Rowan DunneSeptember 9, 2024